Trials / Terminated
TerminatedNCT01221116
Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Ullevaal University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit
Detailed description
Single center, prospective, randomized parallel-group, double-blinded study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levosimendan | levosimendan 0.1 microgram/kg/min) for 24 hours |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2010-10-14
- Last updated
- 2010-11-02
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01221116. Inclusion in this directory is not an endorsement.